Detalhe da pesquisa
1.
Comparison of two assays for molecular determination of rifampin resistance in clinical samples from patients with Buruli ulcer disease.
J Clin Microbiol
; 52(4): 1246-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24478404
2.
National surveillance data on the epidemiology of cholera in Togo.
J Infect Dis
; 208 Suppl 1: S115-9, 2013 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101639
3.
Distribution of quinolone resistance gene (qnr) in ESBL-producing Escherichia coli and Klebsiella spp. in Lomé, Togo.
Antimicrob Resist Infect Control
; 8: 104, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31244995
4.
Sensitivity, Specificity, and Public-Health Utility of Clinical Case Definitions Based on the Signs and Symptoms of Cholera in Africa.
Am J Trop Med Hyg
; 98(4): 1021-1030, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29488455
5.
The African cholera surveillance network (Africhol) consortium meeting, 10-11 June 2015, Lomé, Togo.
BMC Proc
; 11(Suppl 1): 2, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28813542
6.
Treatment Outcome of Patients with Buruli Ulcer Disease in Togo.
PLoS Negl Trop Dis
; 9(10): e0004170, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474069
7.
Loop-Mediated Isothermal Amplification for Laboratory Confirmation of Buruli Ulcer Disease-Towards a Point-of-Care Test.
PLoS Negl Trop Dis
; 9(11): e0004219, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26566026
8.
Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010.
PLoS Negl Trop Dis
; 5(7): e1228, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21811641
9.
Spontaneous clearance of a secondary Buruli ulcer lesion emerging ten months after completion of chemotherapy--a case report from Togo.
PLoS Negl Trop Dis
; 6(7): e1747, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22860147